Home » Topics » Regulatory » Patents

Patents
RSS

Difluoronucleoside antineoplastic and antiherpesvirus agents from Lilly

Oct. 29, 1998

Novel class of vitamin D derivatives for metabolic bone diseases, psoriasis

Oct. 29, 1998

Calpain inhibitors jointly developed by SKB and Cephalon

Oct. 29, 1998

(+)-Enantiomer of known compound acts as potent, selective NMDA receptor antagonist

Oct. 29, 1998

Ionotropic glutamate receptor ligands described by Lilly for CNS disorders

Oct. 28, 1998

New serotonergic agents in development at ADIR for CNS disorders

Oct. 27, 1998

Shiseido claims pyrrolidines for gastric and peptic ulcers

Oct. 27, 1998

Yamanouchi discloses 5-HT2C receptor agonists with high potency and selectivity

Oct. 27, 1998

Korean research institute develops new NMDA receptor antagonists

Oct. 27, 1998

Agents for schizophrenia from Yoshitomi typified by Y-36074

Oct. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...